Reimbursement

topic on 1 show · 2 statements across 2 episodes

the a16z Podcast

2 statements about Reimbursement, every show

a16z Assertion Not checkable as stated
Pande: The commercial hurdle for new drugs is reimbursement, not FDA approval
“In a world where things have gone past clinical trials, but really now the new barrier is not getting past the FDA, the new barrier is reimbursement.”
Vijay Pande Jan 17, 2019 ▶ 19:33 a16z Podcast | Dark Data in Healthcare
a16z Disclosure
Narasimhan: Novartis considers drug reimbursement early in development, not at launch
“It used to be, we think about reimbursement as we got to launch. Now we're thinking about it really early in development.”
Vas Narasimhan Jan 17, 2019 ▶ 10:35 a16z Podcast | The Science and Business of Innovative Medicines

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.